Subject Expert Committee okays Covovax for 12-17 year-olds

The recommendation is yet to be approved by the DCGI. Pune-based SII had last month sought restricted emergency use of Covovax in adolescents. The WHO in December last year allowed emergency use of SII's version of US firm Novavax's Covid-19 vaccine. As of now, only Bharat Biotech's Covaxin is being used to vaccine those in the age group between 15 and 18.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/04JnS5Q
via IFTTT